ExtaviaActive Ingredient(s): Interferon Beta-1b
FDA Approved: * August 14, 2009
Pharm Company: * NOVARTIS PHARMS
Category: Multiple Sclerosis
Interferon beta-1b is a cytokine in the interferon family used to treat the relapsing-remitting and secondary-progressive forms of multiple sclerosis (MS). It is approved for use after the first MS event. Closely related is interferon beta 1a, also indicated for MS, with a very similar drug profile. Contents 1 Mechanism of action 2 Side effects 3 Efficacy 3.1 Clinically isolated syndrome 3.2 Relapsing-remitting MS 4 Commercial formulations 5 References 6 External links Mechanism of ... [wikipedia]* May have multiple approval dates, manufacturers, or labelers.